Combining D-Fraction and Interferon for Prostate Cancer Treatment
Author Information
Author(s): Pyo Paul, Louie Brandon, Rajamahanty Srinivas, Choudhury Muhammad, Konno Sensuke
Primary Institution: Department of Urology, New York Medical College
Hypothesis
Can the combination of IFN-α and D-fraction enhance anticancer activity in prostate cancer cells?
Conclusion
The combination of IFN-α2b and D-fraction significantly reduces prostate cancer cell growth by inducing a G1 cell cycle arrest.
Supporting Evidence
- IFN-α2b alone had no significant effects on cell growth up to 20,000 IU/ml.
- D-fraction alone showed no effects up to 250 μg/ml but reduced growth by ~65% at 1,000 μg/ml.
- The combination of 10 K IU/ml IFN-α2b and 250 μg/ml D-fraction resulted in ~65% growth reduction.
Takeaway
Using two treatments together can help stop prostate cancer cells from growing better than using just one treatment alone.
Methodology
Prostate cancer PC-3 cells were treated with varying concentrations of IFN-α2b and D-fraction, and their effects on cell growth and cell cycle were analyzed.
Limitations
The study was conducted in vitro, and further in vivo studies are needed to confirm the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website